HLA-B58
Human leukocyte antigen serotype
From Wikipedia, the free encyclopedia
HLA-B58 (B58) is an HLA-B serotype. B58 is a split antigen from the B17 broad antigen, the sister serotype B57.[1] The serotype identifies the more common HLA-B*58 gene products.[2] (For terminology help see: HLA-serotype tutorial) B*5801 is associated with allopurinol induced inflammatory necrotic skin disease.
 | ||
| HLA-B (alpha)-β2MG with bound peptide | ||
major histocompatibility complex (human), class I, B58 | ||
| Alleles | *5801, *5802 | |
| Structure (See HLA-B) | ||
| Shared data | ||
| Locus | chr.6 6p21.31 | |
Serotype
| B*58 | B58 | B17 | Sample |
| allele | % | % | size (N) |
| *5801 | 79 | 4 | 2096 |
| *5802 | 72 | 3 | 837 |
Allele distribution
| freq | ||
| ref. | Population | (%) |
| [4] | Cameroon Pygmy Baka | 15.0 |
| [4] | India Khandesh Pawra | 15.0 |
| [4] | Cameroon Sawa | 11.5 |
| [4] | Taiwan Hakka | 10.9 |
| [4] | Kenya Nandi | 10.0 |
| [4] | India West Bhils | 9.0 |
| [4] | China South Han | 8.9 |
| [4] | China Inner Mongolia | 8.8 |
| [4] | India North Delhi | 8.8 |
| [4] | Thailand Northeast | 8.4 |
| [4] | Guinea Bissau | 7.8 |
| [4] | Thailand | 7.7 |
| [4] | India Mumbai Marathas | 7.4 |
| [4] | India Andhra Pradesh Golla | 7.2 |
| [4] | Kenya Luo | 7.0 |
| [4] | Senegal Niokholo Mandenka | 6.9 |
| [4] | India New Delhi | 6.8 |
| [4] | Oman | 6.8 |
| [4] | Russia Tuva (2) | 6.7 |
| [4] | South Korea (3) | 6.5 |
| [4] | Italy Sardinia (3) | 6.4 |
| [4] | Burkina Faso Fulani | 6.1 |
| [4] | Taiwan Siraya | 5.9 |
| [4] | India North Hindus | 5.8 |
| [4] | Burkina Faso Mossi | 5.7 |
| [4] | Cameroon Yaounde | 5.4 |
| [4] | Cameroon Bamileke | 5.2 |
| [4] | Singapore Riau Malay | 5.0 |
| [4] | Saudi Arabia Guraiat and Hail | 4.6 |
| [4] | France Corsica | 4.5 |
| [4] | Sudanese | 4.5 |
| [4] | Zimbabwe Harare Shona | 4.4 |
| [4] | Burkina Faso Rimaibe | 4.3 |
| [4] | Iran Baloch | 4.0 |
| [4] | South African Natal Zulu | 4.0 |
| [4] | Tunisia | 4.0 |
| [4] | Uganda Kampala | 4.0 |
| [4] | Cameroon Beti | 3.7 |
| [4] | Tunisia Ghannouch | 3.7 |
| [4] | Taiwan Pazeh | 3.6 |
| [4] | Tunisia Tunis | 3.4 |
| [4] | Italy North (1) | 3.3 |
| [4] | Israel Ashkenazi and Non Ashkenazi Jews | 3.2 |
| [4] | India West Coast Parsis | 3.0 |
| [4] | China North Han | 2.9 |
| [4] | Ivory Coast Akan Adiopodoume | 2.3 |
| [4] | Mali Bandiagara | 2.2 |
| [4] | Mexico Zaptotec Oaxaca | 2.2 |
| [4] | South Africa Natal Tamil | 2.0 |
| [4] | China Yunnan Nu | 1.9 |
| [4] | Bulgaria | 1.8 |
| [4] | China Tibet Autonomous Region Tibetans | 1.6 |
| [4] | France South East | 1.6 |
| [4] | Israel Arab Druse | 1.5 |
| [4] | Czech Republic | 1.4 |
| [4] | Georgia Tbilisi Georgians | 1.4 |
| [4] | Jordan Amman | 1.4 |
| [4] | Morocco Nador Metalsa (berber) | 1.4 |
| [4] | Croatia | 1.3 |
| [4] | Romanian | 1.3 |
| [4] | Spain Eastern Andalusia | 1.2 |
| [4] | Australian Aborigine Cape York Peninsula | 1.0 |
| B*5802 | ||
| [4] | Cameroon Bamileke | 14.3 |
| [4] | Kenya Luo | 12.5 |
| [4] | Cameroon Yaounde | 10.9 |
| [4] | Cameroon Pygmy Baka | 10.0 |
| [4] | Cameroon Beti | 9.8 |
| [4] | Kenya Nandi | 8.5 |
| [4] | South African Natal Zulu | 8.5 |
| [4] | Cameroon Sawa | 7.7 |
| [4] | Zimbabwe Harare Shona | 6.4 |
| [4] | Cape Verde Northwestern Islands | 5.6 |
| [4] | Uganda Kampala | 4.4 |
| [4] | Central Africa Republic Mbenzele Pygmy | 4.0 |
| [4] | Zambia Lusaka | 2.3 |
| [4] | Iran Baloch | 1.0 |
| [4] | Tunisia | 1.0 |
Disease
HLA-B*5801 is involved in allopurinol sensitive drug induced Stevens–Johnson syndrome.[5][6] Allopurinol is a frequent cause of severe cutaneous adverse reactions, including drug-hypersensitivity syndrome, Stevens–Johnson syndrome, and toxic epidermal necrolysis (SJS/TEN).[7] The association with allopurinol sensitivity in SJS/TEN was extremely strong in Asia, and somewhat less associated in Europeans.[8]